Matthew R. Kwietniak
Overview
Matthew R. Kwietniak received $1M in total compensation, including $360K in salary, at Peregrine Pharmaceuticals in 2023.
Source: SEC filing on August 28, 2023.
Related executives
We found 13 more executives who work or worked at Peregrine Pharmaceuticals.
Nicholas Green
Peregrine Pharmaceuticals
Chief Executive Officer
Daniel Hart
Peregrine Pharmaceuticals
Chief Financial Officer
Mark Ziebell
Peregrine Pharmaceuticals
General Counsel
Richard Richieri
Peregrine Pharmaceuticals
Chief Operations Officer
Richard Hancock
Peregrine Pharmaceuticals
Chief Executive Officer
Roger Lias
Peregrine Pharmaceuticals
Chief Executive Officer
Stephen Hedberg
Peregrine Pharmaceuticals
Principal Financial Officer and Principal Accounting Officer
Paul Lytle
Peregrine Pharmaceuticals